Early-life Exposure to Tobacco Smoke, Metabolomic Perturbation, and Metabolic Dysfunction-Associated Steatotic Liver Disease Incidence Risk in Later Life.
BACKGROUND The association of early-life (in utero, childhood, and adolescence) tobacco smoke exposure (ETSE) with adulthood metabolic dysfunction-associated steatotic liver disease (MASLD) incidence risk and the roles of metabolomic perturbation in explaining the above association and serving as biomarkers for assessi...